EyePoint, Inc. 4

President and CEO Jay S. Duker had 16,667 RSUs in EyePoint, Inc. vest into common stock on July 10, 2026, with 8,059 shares withheld for taxes and no open-market trades.

On July 10, 2026, EyePoint, Inc. President and CEO Jay S. Duker had 16,667 restricted stock units vest and convert into common stock at no exercise price, increasing his directly held common stock to 17,653 shares. To satisfy tax withholding obligations associated with this RSU vesting, 8,059 shares of common stock were withheld by the issuer at an implied price of $14.72 per share, reducing his directly owned balance to 9,594 shares, with 16,667 shares reflected as acquired in connection with the RSU vesting (coded as an “M” transaction) and a corresponding “F” transaction for the shares withheld for taxes. In addition, 177,431 shares of common stock are reported as indirectly owned through a family trust for the benefit of his children, for which Duker disclaims beneficial ownership. No open-market purchases or sales occurred; all activity is related to routine equity compensation vesting and tax withholding.

Filing Facts

CIK

1314102

Ticker

EYPT

Form

4

Source Type

fda

Accession

0001630864-26-000010

Alert Tier

5